have to say this analysis Is spot on, particularly the aggressive accounting stuff. Absolutely nailed it. I think that all leads to a lack of interest in the stock,....I think that will change in time though. To echo your thoughts I think that current CEO is a dead set gun - let’s look at the record - HK/Singapore exit at a 30% premium to book (tick), Exetel acquisition (tick), organic growth (17% this year - tick), net cash (+$47m - tick). There is a big opportunity in this stock because of the terrible big air acquisition that soured its reputation, but a significant turn around is already well in play and it’s trading at 0.7x book value. I concur....love the new CFO has decided no more working capital trickery hence the week cashflow today.....hopefully the accounts are much more straightforward going forward. When I look at this business just annualising the 2H22 performance this business will do around $35m of EBITDA (give or take) in FY23, its capex profile is $20m per annum.....it’s not being valued as a business that is now generating solid free cashflow..
- Forums
- ASX - By Stock
- SLC
- Ann: FY22 Results Presentation
Ann: FY22 Results Presentation, page-13
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.89 |
Change
-0.050(2.58%) |
Mkt cap ! $979.2M |
Open | High | Low | Value | Volume |
$1.91 | $1.93 | $1.89 | $400.0K | 209.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 569 | $1.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.89 | 2351 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 3233 | 1.885 |
8 | 6195 | 1.880 |
4 | 5490 | 1.875 |
3 | 3156 | 1.870 |
3 | 3167 | 1.865 |
Price($) | Vol. | No. |
---|---|---|
1.895 | 4070 | 7 |
1.900 | 4817 | 6 |
1.905 | 4393 | 4 |
1.910 | 2316 | 4 |
1.915 | 2508 | 4 |
Last trade - 13.09pm 13/11/2024 (20 minute delay) ? |
Featured News
SLC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online